MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T cell responses
Cornelia Heuberger(Roche (Switzerland)), Kevin J. Maloy(University of Glasgow), Claire Pearson(Wayne State University), Sebastian Pott(University of Chicago), Yisu Gu(University of Oxford), Alina Janney(University of Oxford), Matthias Friedrich(Nuffield Orthopaedic Centre), Alice Bertocchi(IRCCS Humanitas Research Hospital), Nicholas E. Ilott(University of Oxford), Elizabeth H. Mann(Nuffield Orthopaedic Centre), Mathilde Pohin(Nuffield Orthopaedic Centre), Emily Thornton(University of Oxford), Johanna Pott(Organ Technologies (Japan)), F. M. Powrie(University of Oxford)
Cited by 3
Related Papers
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
|Cancer Cell|2021|486
IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies
|Nature Medicine|2021|289
The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation
|eLife|2016|189
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
|Nature Immunology|2024|83